Noradrenaline versus usual blood pressure care during non-cardiac surgery
Official title: The Effect of Noradrenaline Infusion Versus Standard Blood Pressure Management on Perioperative HYPotension in NOn-caRdiac Surgery HYP-NOR Trial
Run by Jagiellonian University · NCT06885268 · Data updated 2026-11-12
This test tries a continuous noradrenaline infusion during and for four hours after non-cardiac surgery to see if it reduces episodes of low blood pressure in adults aged 45 and older compared with usual blood pressure care.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 750 (estimated) |
| Sponsor | Jagiellonian University Academic / other |
| Locations | 5 sites (Katowice and 4 other locations) |
| Status | Recruiting |
| Started | June 24, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT06885268 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45 or older scheduled for elective or accelerated non-cardiac surgery lasting at least one hour who require general or neuraxial anaesthesia, expect an overnight hospital stay, and are ASA class II or higher.
✕Probably not a fit
Patients with uncontrolled or very high blood pressure, persistent atrial fibrillation, documented dementia, significant sensory or language impairments, surgeon-requested permissive hypotension, or other protocol exclusions are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults having elective or accelerated non-cardiac surgery expected to last at least one hour are randomized to receive either a continuous perioperative noradrenaline infusion (continued up to four hours after surgery) or standard reactive blood pressure management. The trial is open-label to clinicians, while continuous non-invasive blood pressure is recorded covertly using a volume-clamp method and routine intermittent measurements guide care. All participants receive standardized intraoperative care including balanced crystalloids at 4 ml/kg/hour and recommended tidal volumes of 8 ml/kg predicted body weight, with attention to volume status, depth of anaesthesia, positioning, and prompt treatment of reversible causes of hypotension. The primary aim is to see whether proactive noradrenaline reduces the duration and severity of perioperative hypotension compared with reactive treatment.
Why it matters
Potential benefit: If successful, proactive noradrenaline could reduce the time patients spend with low blood pressure around surgery and may lower complications associated with perioperative hypotension.
How similar studies have gone: Prior smaller perioperative studies of prophylactic vasopressors (including noradrenaline and phenylephrine) have reduced episodes of intraoperative hypotension, but large trials showing clear reductions in downstream clinical complications remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥45 years old 2. Elective or accelerated\* non-cardiac surgery expected to last ≥1 hour and requiring general, neuraxial, or combined general with neuraxial anesthesia 3. Expected to stay overnight in the hospital after surgery 4. Written informed consent to participate in the HYP-NOR Trial provided 5. American Society of Anesthesiologists (ASA) physical status class II or higher. Exclusion Criteria: 1. Newly diagnosed, untreated, or uncontrolled hypertension -in two measurements on the day before surgery Systolic Blood Pressure (SBP) ≥180 mm Hg or Diastolic Blood Pressure (DBP) ≥110 mm Hg 2. Persistent difference in recorded SBP between right and left upper limb \>10 mm Hg 3. Persistent atrial fibrillation 4. Have a documented history of dementia 5. Have language, vision, or hearing impairments that may compromise cognitive assessments 6. Have a condition that precludes routine blood pressure management such as surgeon request for relative hypotension 7. Receiving irreversible nonselective monoamine oxidase inhibitors (e.g. tranylcypromine, phenelzine) within 2 weeks preceding study enrolment 8. The use of tricyclic antidepressants 9. Have Prinzmetal angina 10. Have contraindications to noradrenaline per clinician judgement 11. Noradrenaline infusion started before surgery or plan to use continuous noradrenaline infusion throughout the procedure 12. Treating physician (surgeon/anaesthetist) decides on the necessity of extended continuous hemodynamic monitoring during or after surgery 13. Severe kidney disease (MDRD creatinine clearance \<15 mL/min/1.73m2) or renal replacement therapy 14. End-stage heart failure: defined as NYHA Class IV - severe limitations in daily activity. Patients experience symptoms even while at rest. Mostly bedbound patients. 15. Known severe liver disease: defined as the presence of liver cirrhosis or any of the symptoms of severe liver dysfunction: portal hypertension (esophageal varices, ascites), hepatocellular insufficiency (e.g., jaundice, hepatic encephalopathy) and coagulopathy (prolonged INR/APTT associated with known liver dysfunction). 16. Emergency and urgent surgery defined as performed within 24 hours of sudden illness/unplanned admission to hospital 17. Have previously participated in the trial: patient already took a part in the HYP-NOR trial in the past 18. Pregnant or breastfeeding women.
Where it's running
-
Uniwersyteckie Centrum Kliniczne im. Prof. Kornela Gibińskiego Śląski Uniwersytet Medyczny
Katowice, Poland Recruiting -
5 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej w Krakowie
Krakow, Poland Recruiting -
Uniwersytecki Szpital Kliniczny w Opolu
Opole, Poland Recruiting -
Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Stanisława Szyszko Śląskiego Uniwersytetu Medycznego w Katowicach
Zabrze, Poland Recruiting -
Wojewódzki Szpital Specjalistyczny w Olsztynie
Olsztyn, Poland Active not recruiting
Study contacts
- Study coordinator: Bożena Seczyńska, PhD
- Email: bozena.seczynska@uj.edu.pl
- Phone: (+48) 124332847
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remimazolam vs propofol for stable blood pressure during thoracic/abdominal endovascular aortic repair
This trial tests whether remimazolam keeps blood pressure steadier than propofol during TEVAR or EVAR in adults.
-
Remimazolam vs. Propofol for Maintaining Anesthesia During Major Liver Resection
This study tests whether remimazolam keeps blood pressure steadier than propofol during major liver surgery in adults.
-
Remimazolam versus Midazolam for anesthesia induction in older adults
This observational study compares remimazolam and midazolam when inducing anesthesia in people aged 65 and older undergoing elective non-cardiac surgery to see which provides better stability and safety.
-
Keep blood pressure at 85 or more during surgery to prevent delirium in older adults with hypertension
In older adults with high blood pressure undergoing non-heart surgery, researchers test if keeping mean arterial pressure at or above 85 mmHg during surgery reduces postoperative delirium.
-
Internal Jugular Vein Collapsibility to Predict Hypotension in Older Adults Undergoing Laparoscopic Colorectal Surgery
This study tests whether measuring the internal jugular vein collapsibility index can predict intraoperative hypotension in patients aged 60 and older undergoing elective laparoscopic colorectal surgery.
-
Can neck vein ultrasound predict low blood pressure and kidney injury during abdominal surgery?
This observational study tests whether ultrasound measurements of the internal jugular vein can help predict low blood pressure during anesthesia induction and possible kidney injury after abdominal surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.